A Randomized, Double-Masked Clinical Trial Comparing Four Periodontitis Treatment Strategies: 1-Year Clinical Results

被引:41
|
作者
Preus, Hans R. [1 ,2 ]
Gunleiksrud, Therese Mehlum [2 ]
Sandvik, Leiv [1 ]
Gjermo, Per [1 ]
Baelum, Vibeke [3 ]
机构
[1] Univ Oslo, Fac Dent, Dept Periodontol, Inst Clin Odontol, Oslo, Norway
[2] Holtan Clin, Bo, Telemark, Norway
[3] Aarhus Univ, Dept Dent, Fac Hlth Sci, Aarhus, Denmark
关键词
Anti-bacterial agents; dental scaling; metronidazole; periodontal attachment loss; randomized controlled trial; root planing; MOUTH ULTRASONIC DEBRIDEMENT; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; SYSTEMIC METRONIDAZOLE; ANTIMICROBIAL THERAPY; ANTIBIOTICS; DISEASE; DISINFECTION; AMOXICILLIN; DEFINITIONS;
D O I
10.1902/jop.2012.120400
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The benefit of full-mouth disinfection (FDIS) over traditional scaling and root planing (SRP) remains equivocal, and it is not known whether the use of adjunctive antibiotics may enhance the effect of FDIS. The aim of the present study is to test the hypothesis that there is no difference in the 1-year clinical outcome of therapy among groups of patients treated with conventional SRP performed over 2 to 3 weeks, or same-day FDIS, with or without adjunctive metronidazole. Methods: A total of 184 patients with moderate-to-severe periodontitis were randomly allocated to one of four treatment groups: 1) FDIS+metronidazole; 2) FDIS+placebo; 3) SRP+metronidazole; or 4) SRP+placebo. Recordings of plaque, bleeding on probing, probing depth (PD), and clinical attachment level (CAL) were carried out in four sites per tooth at baseline and at 3 and 12 months after treatment. Results: No differences were observed in the mean CAL or PD values between the four experimental groups at baseline and 3 or 12 months post-treatment. All four groups displayed significant improvements in all parameters. However, using absence of pockets 5 mm as the criterion for treatment success, the two groups receiving adjunctive metronidazole performed significantly better than the two placebo groups. Conclusion: Metronidazole had a significant, adjunctive effect in patients with a metronidazole-sensitive subgingival microbiota on the clinical parameters of CAL, PD, and absence of pockets >= 5 mm.
引用
收藏
页码:1075 / 1086
页数:12
相关论文
共 50 条
  • [21] BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy
    de Araujo, Carla Adriane Leal
    Ray, Joel Geoffrey
    Figueiroa, Jose Natal
    Alves, Joao Guilherme
    BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)
  • [22] Local Drug Delivery of Alendronate Gel for the Treatment of Patients With Chronic Periodontitis With Diabetes Mellitus: A Double-Masked Controlled Clinical Trial
    Pradeep, A. R.
    Sharma, Anuj
    Rao, Nishanth S.
    Bajaj, Pavan
    Naik, Savitha B.
    Kumari, Mina
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (10) : 1322 - 1328
  • [23] Double-masked, randomized home-use clinical trial of a wearable collision warning device for the blind: preliminary results
    Pundlik, Shrinivas
    Baliutaviciute, Vilte
    Moharrer, Mojtaba
    Bowers, Alex R.
    Luo, Gang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [24] Are There Specific Benefits of Amoxicillin Plus Metronidazole in Aggregatibacter actinomycetemcomitans-Associated Periodontitis? Double-Masked, Randomized Clinical Trial of Efficacy and Safety
    Mombelli, Andrea
    Cionca, Norbert
    Almaghlouth, Adnan
    Decaillet, Fabien
    Courvoisier, Delphine S.
    Giannopoulou, Catherine
    JOURNAL OF PERIODONTOLOGY, 2013, 84 (06) : 715 - 724
  • [25] Clinical cure of bacterial conjunctivitis with azithromycin 1%: Vehicle-controlled, double-masked clinical trial
    Abelson, Mark B.
    Heller, Warren
    Shapiro, Aron M.
    Si, Erwin
    Hsu, Peng
    Bowman, Lyle M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (06) : 959 - 965
  • [26] Response to comment on ‘Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial’
    M L Subramanian
    Eye, 2011, 25 : 820 - 820
  • [27] Response to comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'
    Wakefield, M. J.
    Tole, D. M.
    Bailey, C. C.
    Mundasad, M. V.
    Sparrow, J. M.
    EYE, 2011, 25 (06) : 821 - 821
  • [28] Punctal Plug Retention Rates for the Treatment of Moderate to Severe Dry Eye: A Randomized, Double-Masked, Controlled Clinical Trial
    Brissette, Ashley R.
    Mednick, Zale D.
    Schweitzer, Kelly D.
    Bona, Mark D.
    Baxter, Stephanie A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (02) : 238 - 242
  • [29] A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
    Smith, JA
    Thompson, DJS
    Whitcup, SM
    Suhler, E
    Clarke, G
    Smith, S
    Robinson, M
    Kim, J
    Barron, KS
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (01): : 18 - 23
  • [30] Should snacks be recommended in obesity treatment? a 1-year randomized clinical trial
    H Bertéus Forslund
    S Klingström
    H Hagberg
    M Löndahl
    J S Torgerson
    A K Lindroos
    European Journal of Clinical Nutrition, 2008, 62 : 1308 - 1317